Fort Dodge Animal Health has announced that its Duvaxyn WNV vaccine against West Nile Virus (WNV) is now available in the UK, following its licensing through the European Medicines Agency (EMEA).
Duvaxyn WNV is the first vaccine available in Europe to protect horses against this emerging disease threat. 288 horses and two people in Italy were found to be infected with WNV during the outbreak that hit northern Italy in late 2008 where it is now considered endemic. The disease is endemic in all areas of North America where it has claimed the lives of both horses and humans.
West Nile Virus is caused by a highly contagious flavivirus, which is transmitted by mosquitoes, primarily of the Culex species. The natural hosts of West Nile virus are birds, with migratory birds from Africa carrying the disease. Mosquitoes become infected after taking a blood meal from infected birds and then may transmit the disease to horses and even humans. While horses are 'dead end hosts,' the consequences can be severe as the virus causes encephalitis or meningitis. Mortality rates among horses which develop neurological signs are high and there is no palliative cure for the disease. Treatment is limited to symptomatic relief which can be long and expensive.
Sabrina Jordan, UK Business Manager for Equine Vaccines at Fort Dodge said: "WNV is an increasing threat to the equestrian sector in the UK and is a particular challenge for owners who transport their horses around the world.
"The fact that a vaccine is now available will undoubtedly offer peace of mind to the equestrian community. They can be reassured that horses in the UK can now be vaccinated against WNV with a vaccine that has already been shown to be highly effective in protecting horses in America.
"With any vaccine, a record that a horse has been vaccinated with Duvaxyn WNV should be recorded in its horse passport. By presenting this vaccine in pre-filled syringes with Infovax-ID labels, we've aimed to make both the administration and record keeping of Duvaxyn WNV as convenient as possible.
"To build understanding of this potentially fatal disease threat, we are continuing to work with governments and authorities at a national and European level, as well as working in partnership with the UK's veterinary community to ensure that owners are fully informed about the risk WNV poses and of the benefits of vaccination."
The Royal College of Veterinary Surgeons has embarked upon the most extensive review of its veterinary nursing qualifications for many years, in order to meet the timetable for Ofqual's implementation of the Qualifications and Credit Framework (QCF) in summer 2010.
The new QCF aims to provide a more user-friendly and flexible system. Under the new arrangements, all qualifications will carry a 'value' in terms of their level and the volume of learning involved. It's a similar system to that used in higher education for a number of years.
The new national awards framework means that NVQs as such will disappear and the process of review opens up the whole qualification structure, allowing for the creation of a more flexible system to suit better the needs of the veterinary nursing profession and employers.
Head of Veterinary Nursing, Libby Earle said: "Future options include potentially placing more of the responsibility for education and basic skills on the colleges, leaving practices to concentrate on providing quality mentorship and work experience, with less emphasis on assessment.
"Consideration will also be given to providing part of VN training and education within full-time further education, which is possible now that the lower age limit for VN students has been dropped."
The College is keen to hear the views of those involved with the delivery of training and employers of qualified nurses. A consultation letter has been sent to those involved and topics on which views are sought include the range and level of knowledge and skills delivered by the current awards, the impact of training on employers of student VNs, meeting the increased demand for qualified VNs, and providing VNs for mixed or equine practices.
Over the summer, evidence-gathering meetings will be held at the RCVS to explore the issues in more depth. Anyone who has not been sent a formal consultation letter and who would like to contribute is very welcome to submit their views. Please visit www.rcvs.org.uk/vnawardsreview for the consultation papers. Comments should be submitted by 30 June 2009.
The review of the RCVS awards will take place alongside Lantra's review of the National Occupational Standards (NOS) for VNs: the NOS describe what a person needs to do, know and understand in their job to carry out their role in a consistent and competent way.
Hill's Pet Nutrition has released the results of a survey of how last year's graduates feel about clinical nutrition.
Despite teaching of clinical nutrition moving up the agenda for most vet schools, over one third of respondents said that they did not feel confident about applying their knowledge of pet nutrition to clinical cases. The remaining two thirds claimed to be reasonably confident but no respondent felt very confident in this area.
When it comes to advising clients 86 per cent would make a nutritional recommendation for their clinical cases but of those, half left it up to the nurse to decide on the brand of food. For 14 per cent of the new graduates, the decision was made to allow nurses to decide on the type of nutrition and brand.
The respondents were also asked about their preferred form of nutritional CPD support. Despite the advances in on-line CPD, the majority expressed a preference for face-to-face teaching in the form of in-clinic updates from reps, speaker tours and roadshows. However e-updates and on-line courses were preferred over paper correspondence courses.
Adrian Pratt, Veterinary Affairs Manager at Hill's Pet Nutrition said: "We recognise that our short survey dealt with only a small number of respondents but it gave us much food for thought. It's disappointing, for ourselves, but more so for the newly qualified vets, that a significant number don't feel confident about making nutritional recommendations. Having been in those 'new vet' shoes, I have to wonder whether this is a crisis of confidence or actually founded on a real or perceived lack of knowledge and also whether this is a finding that applies only to nutrition or affects other areas too. We would very much like to know the answers to these questions because we think that this could be a source of very considerable stress to the individuals concerned.
"Our survey doesn't really tell is whether this is resulting in vets delegating nutritional matters to their nurses because nurses are seen to have at least equivalent, or possibly greater knowledge of nutritional matters and are respected as fellow professionals, or whether these cases are being passed to the nurses with a sigh of relief because the vet doesn't feel able to deal with them. I also found it interesting that vets did not want to be seen to be actively recommending a particular brand, despite the wide variations in clinical evidence and nutritional make up between brands. I do wonder if there could be a perception here that 'brand' is a commercial decision that can be made by another member of the healthcare team, rather than a clinical decision."
Marge Chandler, DVM, MS, DACVN, MACVSc, DACVIM, DECVIM-CA, MRCVS is one of the two American College of Veterinary Nutrition diplomates in the UK (along with Dr Dan Chan) and believes that nutrition is well integrated at the R(D)SVS, "In addition to the general basics, we also teach the basics of small animal nutrition for healthy adult cats and dogs, kittens and puppies, with some emphasis on the special needs of cats. During the clinical lectures there is information provided for disease specific nutritional needs, for example with chronic kidney disease, liver disease, and gastrointestinal disorders. In their final year, our students are given an interactive tutorial on clinical nutrition for hospitalized small animal patients. In addition to this tutorial, we discuss the patients' nutritional requirements and supplementation during rounds, and there is a nutrition form for each medicine in-patient requiring supplementation."
For those who need access to good quality post-graduate CPD on the topic, Hill's has just launched the latest Veterinary Nutrition Academy (VNA) course. VNA Level 3 is all about applying nutritional principles to make a recommendation appropriate to a clinical case. Anyone who would like to brush up on the topic can register with VNA - registration and the course itself is free of charge. VNA also gives access to booking forms for Hill's roadshows and other events.
Adrian said: "While face-to-face training events are still proving to be highly popular, it is clear that travel time and cost can significantly hinder access to CPD particularly for those with family commitments or in geographically remote locations and our on-line training courses are continuing to grow in popularity."
Registration to VNA is free at www.myhillspet.com/vna. To complete registration the practice U number will be required and this is available by contacting Jane Quail at Hill's on 01923 814454.
Lucy Evans and Jamie Hollis, who work in the RCVS Professional Conduct Department, will join RCVS Trust Director Cherry Bushell to raise funds in the British 10K London Run on 12 July.
None of the three runners have run any kind of race since their school sports days - and are appealing for support as they aim to raise at least £300 each for the Trust.
To sponsor a runner, you can log onto http://www.justgiving.com/rcvstrust and, if you are a UK tax-payer, this also means the Trust gets your tax back. Or, if you prefer to send a cheque, sponsorship forms are available from info@rcvstrust.org.uk or 020 7202 0743.
Lucy said: "The RCVS Trust is a great charity which supports veterinary education and has specialist library and information services for vets and VNs to use. Small charities like the Trust can get overlooked in big fundraising events so I'm glad to be able to help out - even if the thought of running 10K is a bit daunting!"
The race will be broadcast through the British 10K London Run website: http://www.thebritish10klondon.co.uk/.
VetSurgeon.org has launched a new collaborative publishing section of the website (called a wiki) in which any member of the site may publish case studies and reports, abstracts, short communications, research papers and the results of clinical audit for open discussion and review by all.
The state-of-the-art systems in use on VetSurgeon then allow all members to comment on the work submitted. Initially, it's hoped that this will stimulate valuable further debate, discussion and critical review of papers that have already been published elsewhere. However, another benefit of this system is that it enables anyone in the profession to publish their research to the veterinary community immediately, without being at the mercy of such things as the availability of space in a traditional print journal, so original work is warmly welcomed.
Arlo Guthrie, editor of VetSurgeon said: "Of course I recognise that authors still want the kudos of publication in a traditional peer reviewed journal. However, in addition to offering immediate publication, this system also opens the review process up so that everyone in the profession can participate in a completely open way. If it works, it may even come to be thought of as a more stringent and robust method of review than the traditional method. Or perhaps more likely, peer review could become a two stage process in which work is assessed by a panel of experts and then by the sort of 'open review' offered by VetSurgeon.org."
Doubtless there will be concerns about the validity of information published in this new section of VetSurgeon, primarily because it may NOT have been subject to peer review at the time of publication. Arlo said: "I don't think this is an issue. VetSurgeon members should just have a different starting point. When you read content in, say Vet Record, you can presume it's been scrutinised and read it in that context. On VetSurgeon, you should assume the opposite, and then use the tools offered by the site to judge the value of the work yourself."
Ways of assessing work published on VetSurgeon.org include:
In phase one of this project, taking place over the coming few days, all abstracts published in Veterinary Practice magazine are being uploaded to the new wiki.
Click here to visit the new VetSurgeon Wiki
AB Science, a young Paris-based biotech company, has announced the pan-European commercial launch of its veterinary anticancer drug, Masivet
Masivet was approved in November 2008 by the European Medicines Agency (EMEA) for the treatment of dogs with non-resectable grade 2 or 3 mast cell tumours. Masivet's active pharmaceutical ingredient is masitinib, a tyrosine kinase inhibitor. Masitinib, discovered and developed by AB Science, belongs to a therapeutic class of drug known as targeted therapy that is, according to AB Science, revolutionising the treatment of cancer in humans.
Alain Moussy, CEO of AB Science said: "Masivet is the first product ever registered as a cancer treatment in veterinary medicine. AB Science is a dynamic and very entrepreneurial biotech company, and is proud to have introduced a drug that can extend the life of dogs suffering from cancer ahead of the large pharmaceutical companies".
The company says Mastocytoma can be an aggressive cancer with a poor prognosis, and represents up to 20% of all cutaneous canine tumours. Some breeds are particularly susceptible, among them Golden Retrievers, Labradors and Boxers. Cancers have the same prevalence in dogs as in humans (1 dog in 4 will suffer from cancer during its lifetime) but surprisingly, no drugs developed for veterinary medicine with a demonstrated efficacy and safety have ever been approved until the arrival of Masivet.
The company claims two main benefits of the new treatment:
AB Science is a biotech company specialising in developing targeted drugs for high need indications, such as cancers, chronic inflammatory diseases and neurodegenerative disorders. Masitinib is the most advanced drug in the pipeline. Now being marketed in veterinary medicine, masitinib is also under development in humans, with phase 3 clinical studies in pancreatic cancer and in gastrointestinal stromal tumour (GIST).
Alain Moussy said: "This registration in veterinary medicine is good news for the future success of masitinib in humans, for whom we are aggressively developing it in cancers and other indications with high morbidity or pain.
"It is very unusual to develop such an innovative product simultaneously in veterinary and human medicines, and even more so that the product is registered in veterinary medicine first. There is no doubt that experts in human oncology will be watching Masivet's future very closely from now on.. However, people will have to wait a while before benefiting from masitinib because it is unlikely to be available to man before 2012".
For more information, see www.masivet.com and www.ab-science.com
Vetoquinol has announced the launch of Enisyl-FTM, the first L-Lysine supplement developed for veterinary use in the UK and Ireland.
Vetoquinol says a unique distributing pump and paste formulation will aid compliance in cats that require L-Lysine supplementation and make administration of L-Lysine much easier. Each pump action delivers 1ml of Enisyl-F paste at each press, which can be applied directly into the cat's mouth or on the paw to be licked off. It can also be added to food.
Zorica Agbaba, Enisyl-F's Product manager said: "We are delighted to have launched Enisyl-F and I am sure it will prove very useful to veterinary surgeons, especially when it comes to aiding compliance in cats that require L-Lysine supplementation."
To try Enisyl-F or for more information about the product, contact your local Vetoquinol representative or call Vetoquinol main office on 01280 814 500 (UK) or 1800 406 117 (ROI free phone number). Alternatively visit http://www.vetoquinol.co.uk/ website.
CEVA Animal Health has announced that all dogs entering Dogs Trust's 17 Rehoming Centres will now be fitted with a D.A.P.® collar to help reduce their stress levels while in a kennel environment. This decision was taken following a highly successful trial1 at Dogs Trust's state-of-the-art Rehoming Centre in West London.
The trial revealed that dogs wearing D.A.P.® collars while in kennels were less likely to display canine stress indicators, such as barking and pacing around kennels, and were more likely to lie down and rest; signs that dogs are more relaxed.
Chris Laurence, veterinary director at Dogs Trust, said: "Dogs Trust trialled D.A.P.® collars on dogs being admitted at our Harefield Rehoming Centre. Many dogs are very stressed by their first experience in a kennel environment and it was shown that the use of a collar significantly reduced their stress levels.
"Centre staff were impressed with the positive changes in behaviour that were shown during the trial. Dogs were far more relaxed and less reactive to the inevitable stressful elements of their environment. We will now be using D.A.P.® collars on all dogs entering our Rehoming Centres in tandem with the other practices we already employ to reduce kennel stress.
"Stressed dogs are more difficult to rehome so we hope the use of DAP® to reduce stress levels will be beneficial to both their welfare and our rehoming."
For further information on D.A.P.®, please contact your local CEVA Animal Health territory manager, or visit www.ceva.uk.com.
A campaign to reform English libel law to allow for robust criticism of scientific and medical claims without fear of legal action has been launched by journalist and author Simon Singh. It's a campaign which anyone working in the caring professions might wish to support.
The campaign comes as a consequence of legal action taken against Mr Singh by The British Chiropractic Association, which took exception (perhaps unsurprisingly) to an article he'd written in The Guardian. In the article, Mr Singh denounced claims on the BCA website that its members could use spinal manipulation to treat children with colic, ear infections, asthma, sleeping and feeding conditions, and prolongued crying as 'bogus', and criticised the BCA for 'happily promoting' these claims.
Out of curiosity, VetSurgeon rang the BCA press office this morning, and asked to be given the references for studies which it feels would support the original claims made on its site. Non have been forthcoming so far, which is a surprise. Under the circumstances, we'd have expected the BCA would have a raft of supporting evidence readily available.
But this isn't really about whether or not chiropractic works or not. The case seems to hinge upon whether Mr Singh's article implied that the BCA was being deliberately dishonest, or just delusional. He say's the latter. Unfortunately for him, Mr Justice Eady recently ruled the former, leaving Mr Singh with a bill for £100,000 worth of legal fees.
Mr Singh is to appeal. At stake is the freedom to be able to challenge scientific claims without fear of being sued. If you'd like to support this campaign, visit senseaboutscience.com and add your name to the 7000 others (including some pretty illustrious names) who have already done so.
Intervet/Schering-Plough Animal Health has launched a new consumer campaign to support the company's joint care supplement, Cosequin.
The campaign centres around a series of paw-tapping internet videos which showcase the perfectly poised paws of dog and cat dance duo, Fred and Ginger, highlighting the importance of good joint health. The videos are available to view at http://www.cosequin-dance.co.uk/
Pet owners are encouraged to purchase Cosequin from vet practices to enter a prize draw to win a photography day with leading animal photographer, Sam Lunt, or one of ten tickets to an upcoming live dancing tour. Posters and in-practice leaflets are also available for vet practices to help drive awareness and encourage uptake.
Sarah-Jane Minter, Marketing Manager for Intervet/Schering-Plough, commented; "We wanted to create a campaign which would support vets in practice and attract the attention of pet owners, especially those who may not have previously thought about the joint health of their pet. With these lighthearted new videos of Fred and Ginger demonstrating everything from the jive to the rumba and an eye-catching print campaign, we certainly expect to grab pet owners' attention!"
ISPAH says that by supporting joint condition and maintaining not only healthy cartilage, but also healthy joint structures, Cosequin is suitable for all dogs and cats that need some joint support, especially highly active or older animals. It adds that the joint care supplement contains 100% pure chondroitin sulphate and the unique formulation has been proven in over 50 clinical trials.
For further information, please contact your local Intervet/Schering-Plough Veterinary Business Manager or phone the company's Veterinary Support Group on 01908 685685.
A European study undertaken in horses to evaluate the efficacy of the key anthelmintic molecules fenbendazole, pyrantel, ivermectin and moxidectin in treating equine cyathostomins, has confirmed that resistance is developing against all the molecules with the exception of moxidectin.
Resistance to fenbendazole was highlighted as a particular issue with 80% of the yards tested in the UK and Germany showing resistance. Resistance to pyrantel also proved to be increasingly prevalent while cases of ivermectin resistance were emerging.
The Fort Dodge-sponsored study, the largest of its kind so far undertaken, took place during 2008 and was led by scientific teams from veterinary faculties in Italy and Germany. It was based on Faecal Egg Count Reduction Tests (FECRTs) of 1,704 horses at 102 yards in Italy, Germany and the UK. The calculation of FECR data was performed employing bootstrap analysis of group arithmetic means.
The study concluded that:
According to Dr Donato Traversa from the University of Teramo, Italy, who headed up the field work, the results confirm that single and even multiple drug resistance in equine cyathostomins is an increasing challenge in all three countries with resistance to fenbendazole and pyrantel a particular concern.
He said: "Our research highlights the necessity for vets, owners and managers to use those anthelmintic molecules that remain most effective in a manner which preserves their efficacy for as long as possible."
Professor Georg von Samson Himmelstjerna from Hannover University of Veterinary Medicine, which participated in the research, added: "Given the strong impact that resistant cyathostomins are likely to have on horse welfare, future parasite control plans should be based on integrated measures, involving both the correct use of anthelmintics, such as administering the correct dosing according to the animals weight, and only using products in the species for which it is licensed, as well as other approaches such as adequate pasture hygiene, low stocking rates and mixed grazing with other animals.
"We call on all concerned with equine health and welfare to take an active role in planning and monitoring effective worm control programs."
The Blue Cross is calling for nominations from veterinary practices across the country for its Veterinary Nurse of the Year Award 2009.
The annual award is presented at the British Veterinary Nursing Association (BVNA) Annual Congress. It recognises the contribution of veterinary nurses in educating the public about responsible pet ownership and the welfare of pets in the community. This year's Congress will take place on 9-11 October at the Kettering Conference Centre, Northamptonshire.
Last year's award was won by Rebecca Darbyshire for her outstanding contribution to animal welfare, both within her veterinary practice and among the local community in Pocklington, York.
Rebecca Darbyshire was nominated by vet and colleague Matt Brash at Battlefields veterinary clinic in Pocklington.
Mr Brash said: "Rebecca is an outstanding, unassuming professional nurse. She runs all of the clinics that a modern day nurse does, but still has the time for anybody - whatever they need, whenever they need it. She has developed such a close relationship with our clients that they would often rather see her than a vet!"
Nominations for this year's award can be made by completing the nomination form on The Blue Cross website at: www.bluecross.org.uk/BVNA2009 or by contacting Sally Leathem on 01993 825577. The deadline for nominations is Friday 14 August 2009.
The Blue Cross has taken the lead in animal care for over a hundred years. Its four animal hospitals provide a lifeline for pet owners on low incomes. Its community vet services also cater for elderly and disabled people. Without the charity's hospitals, and the services they provide, many people would be without the benefits that pet ownership can bring.
Abbott Animal Health is launching GLUture Topical Tissue Adhesive this month.
Abbott says GLUture is an Octyl/Butyl cyanoacrylate blend that creates a strong and flexible bond that contours to the wound site. GLUture applies purple for visibility and dries clear for a neat cosmetic appearance. Offered in an economical multi-use package with 10 applicators, GLUture's viscosity and applicator design enable flow-controlled application. GLUture topical tissue adhesive offers a flexible seal, quick application and a strong bond.
For more information, ring Abbott on 01628 644354, or visit: www.abbottanimalhealth.com
Fort Dodge has released figures today which point to a continued modest slowdown in the UK veterinary sector, being mitigated by a slight increase in average transaction value (the amount a client spends in a year).
Matthew Rowe, Companion Animal Marketing Manager at Fort Dodge, said: "It's been clear for some time that the veterinary sector is being hit by static growth and an increasingly competitive environment. The reduction in turnover being experienced by many practices is primarily down to current clients visiting less often and fewer new clients being attracted."
Key findings of the Fort Dodge Index for the first quarter of 2009 are:
Alan Robinson said: "In the current climate, the only contributor to turnover growth in many practices seems to be a steady rise in the price of professional fees, consultations and surgery. These have continued to push up average transaction values (by 1.4%) and client values (1.2%) in this first quarter of 2009 despite reducing visit frequency. Drug related income increases seem to be driven by a small increase of POM mark-ups in many practices.
"But this alone will not sustain a successful business and, with transaction volumes still falling, the priority for practices is to maintain client footfall despite increasing competition and falling pet ownership. In today's market, retaining clients is a cheaper and more effective way to maintain client and patient numbers so an emphasis on 'bonding' clients though preventative health care and heath maintenance programmes is key.
"We're seeing a steady increase in the number of practices running these programmes but the percentage of pets involved is still woefully low so the message is that practices can and must do better.
Fort Dodge has announced that a challenge study has demonstrated the ability of Duvaxyn® IE-T Plus equine influenza vaccine to cross protect against A/equi-2/Sydney/07 (H3N8) two weeks after a two dose primary course. This strain was responsible for the financially devastating equine influenza outbreak in Australia in August 2007.
Duvaxyn IE-T Plus is an inactivated whole virus equine influenza vaccine, adjuvanted with an aqueous-based adjuvant. According to Fort Dodge, experts at a recent WHO meeting on human vaccines expressed the view that whole virus vaccines have the potential to induce a stronger and more broadly based response to circulating influenza strains than those contained in sub-unit vaccines because of the presence of the full set of virus proteins in the vaccine*.
The study, conducted by the Animal Health Trust, involved two groups of EIV seronegative horses. The first group, consisting of seven vaccinates, were given two dose of Duvaxyn IE-T Plus, 28 days apart, and challenged with A/equi-2/Sydney/07 (H3N8) virus strain 14 days after the second vaccination. The second group of unvaccinated horses was challenged at the same time. Duvaxyn IE-T Plus caused a statistically significant reduction in both clinical signs of the disease and in viral shedding.
Helen Barnes, EMEA Equine Business Manager for Fort Dodge, said: "The results of this challenge study provide reassurance for owners that horses vaccinated with Duvaxyn will be protected against circulating strains of equine influenza, including the Sydney strain which proved so damaging.
"As the benefits offered by whole virus technology are increasingly recognised, the popularity of vaccines based on this technology is re-emerging, particularly to combat a potential pandemic.
"The entire Duvaxyn range of equine vaccines, including the recently licensed Duvaxyn WNV for West Nile Virus, are based on the whole virus approach as we believe it offers a broad and consistent level of protection."
A You Gov poll commissioned by Intervet/Schering Plough in the run up to National Vaccination Month (1st-30th June) shows the degree to which the recession is now biting into veterinary spending, and the impact it's having on vaccination levels.
The You Gov survey found that 19% of pet owners nationwide admit they have cut back on veterinary expenses such as vaccinations, health checks and treatments. Just under half are failing to vaccinate their animals with 53% of those polled not vaccinating their pets due to cost.
Other key findings of the You Gov survey include:
The You Gov survey also highlighted a lack of awareness among younger pet owners about pet health. Of the 18-24 year olds polled who had not taken their pet to be vaccinated, 44% said it was because they were unaware of any disease risk to their animals, compared to just 13% of those aged 55 and over. 22% of 18-24 year olds surveyed were not aware of zoonoses such as fleas and worms and diseases such as ringworm and Toxocara.
Matt Brash, BVetMed MRCVS, who runs a small animal veterinary clinic in North Yorkshire and is star of the TV show 'Zoo Vet at Large' said: "These figures are concerning and we could be sitting on a ticking time bomb. The simple fact is that many pet owners don't realise that their pets are at risk of disease. Less than half of all dogs and cats are vaccinated, which is well below the amount needed to protect the pet population through herd immunity."
Paula Boyden, a vet and Business Development and Corporate Marketing Project Manager at Intervet/Schering-Plough Animal Health, who has steered the campaign for the company said: "There are clearly some strong messages coming out to vets here, not least where and how the credit crunch is hitting pet owners. The underlying message that National Vaccination Month offers a way of supporting pet owners during these difficult economic times is obviously important. While the data shows that pet owners will still make considerable sacrifices to care for their pets, it also highlights that vaccination is falling by the wayside. Clearly, practices will need to work harder than ever against the background of the credit crunch to bring home the message to pet owners that their pets are at risk of serious and often fatal disease and that cutting vaccination is a false economy. The You Gov poll also highlights the urgent need to educate the younger section of pet owners about the disease threat faced by their animals."
TV wildlife and science presenter Kate Humble, who with Matt and Clare Brash is spearheading the National Vaccination Month Campaign, said: "The really sad aspect is that people who are reducing veterinary care due to the recession may be making a false economy by putting their pets at risk of serious disease, which may lead to treatment at far greater cost than the price of the annual jab."
The You Gov survey suggests that where people have had to pay for unexpected vet bills they are paying for them on credit cards. One had to put the family pet down and many revealed that they had made personal sacrifices in order to keep looking after their animals including stopping smoking, cutting out luxuries, clothes and socialising.
The You Gov survey highlights how, despite lavishing affection and presents on their pets, people are not taking adequate steps to protect them from preventable killer diseases. The survey reveals that 65% of pet owners consider their animal to be an extremely important member of the family with over half (54%) buying them Christmas presents. However, only 56% of pets were vaccinated with just under a quarter (22%) of owners unaware of any disease risk.
Currently, an estimated 3 million dogs, 6 million cats, 1.8 million rabbits and 500,000 horses are unvaccinated.
In answer to this disease threat and to help owners during the recession, around 2,000 veterinary clinics across the UK have so far signed up to part in the National Vaccination Month campaign, offering pets a full vaccination course against a range of fatal diseases for the cost of a booster.
To participate in National Vaccination Month (www.vaccinationmonth.co.uk) - the biggest national consumer campaign of its kind, please contact your Intervet/ Schering-Plough Animal Health account manager or call Intervet/ Schering-Plough's Veterinary Support Group on 01908 685685, option 4.
Pet Blood Bank UK (PBBuk) launched its new mobile blood collection unit, donated by Royal Canin, at the University of Nottingham's School of Veterinary Medicine and Science on Wednesday, simultaneously collecting enough blood to save the lives of up to 32 dogs.
The blood collection session offered third-year university students an opportunity to learn about transfusion medicine and to practice their clinical skills on real life subjects, as they performed the pre-donation checks and tests under the supervision of Pet Blood Bank UK veterinary advisers.
Vanessa Ashall, Pet Blood Bank UK welfare officer and veterinary surgeon, said: "It is great for students to be able to see these animals. Transfusion medicine is a new science and I certainly wasn't taught about it as a veterinary student. Collaboration with veterinary schools is such a positive step, as we are able to educate the vets of the future on the benefits of transfusion medicine and blood typing, whilst giving them some real hands-on experience."
Veterinary support manager for Royal Canin, Chris Geddes, said: "We are really pleased to be able to assist Pet Blood Bank UK become more mobile and reach more donors. The charity's work is so important to the emergency and critical care of patients, as shown by the tremendous gratitude of the owners of blood recipients."
Golden retriever Beau was one such recipient who had received a transfusion last month after suffering a haemorrhage after surgery for gastric dilatation and volvulus. His owners, Janet and David Liggins, attended the event with a fully-recovered Beau and their other golden retriever, Lotti who gave blood.
Mrs Liggins said: "We can't speak highly enough of all the vets and vet nurses that cared for him - they did a tremendous job looking after Beau, and us! The Pet Blood Bank provided the blood that saved Beau's life. We are really pleased that Lotti was able to give blood. She was a star - the perfect donor!"
Veterinary practices wanting to encourage their clients to put dogs forward as donors, or which would like to support the work of Pet Blood Bank UK, should visit http://www.petbloodbankuk.org/ or contact Pet Blood Bank UK on 01509 232 222 or 0844 800 9925 (5p/min). Blood donors are needed for a second blood collection session at the Nottingham School of Veterinary Medicine and Science, Sutton Bonington campus, on Saturday, May 23: 10-4pm.
Pfizer has sponsored the publication of a new English-Polish dairy health guide for vets to give farmers.
The guide has been published to help farm staff from Poland improves their knowledge, skills and performance at work. Topics covered including milking routines, causes and control of clinical mastitis, intramammary tube infusion and dry cow therapy.
Copies are available free of charge from Pfizer Animal Health's Dairy Territory Managers, or by calling 01737 330727.
A survey of more than 3,000 farms has found that 16% employed foreign workers, among whom more than half were from Poland.1 According to Pfizer's livestock business director Tomas Rosival, Polish workers are keen on training and eager to put it into practice and get results.
He said: "Communication is the key. By presenting each topic in English and Polish on facing pages, the booklet helps develop workplace vocabulary and language skills as well as improving technical knowledge."
[1] Farm Business, 2009. The significance of migrant labour in UK agricultural employment. Survey of 3,375 farms.
Animals Count, which describes itself as a political party for people and animals, will launch its EU election manifesto on 24th May from 12 noon at the Kings Oak, Loughton, where it will be putting into practice one of its proposed policies: subsidised basic and emergency animal health care for animals. Animals Count President and veterinarian, Andrew Knight, will provide free dog consultations and animal health care advice for all companion animals.
Animals Count will contest the European Parliament elections, taking place on the 4th of June. It hopes to end farming with poor welfare consequences for animals, long distance live animal transport, all hunting for sport, and introduce an EU-wide subsidised basic animal health care system.
Animals Count Leader, Jasmijn de Boo MSc., said: "Concern for animals has long been a mainstream priority, yet remains poorly represented by most political parties. In several countries political parties for animals have formed to meet this need. The Dutch Party for the Animals from which we grew now has 20 elected representatives, including 2 MPs and one senator."
"The EU elections are particularly important for people and animals. Around half the EC budget is spent on agriculture. Given today's economic climate there's never been a better time to re-examine the massive expenditure of tax-payer money on farming methods known to be strongly associated with poor animal welfare and serious environmental damage."
Miss de Boo, 33, Alex Bourke, 47, Vice-chair of Animals Count and best-selling author of the 'Vegetarian Guides' book series, and Richard Deboo, 41, City professional and public speaker on animal issues, will contest the June EU elections in the Eastern region of the UK. Animals Count's ultimate goal is a world in which animals are not exploited, and are treated as sentient beings.
The British Veterinary Dental Association has officially launched its own new section on VetSurgeon.org to help its members share ideas and experiences amongst each other.
The new BVDA section on VetSurgeon contains a dedicated forum for discussing veterinary dentistry. There's also a photo and video sharing gallery in which to share and discuss interesting cases. Members can also catch up on association news and hold private 'conversations' between each other using VetSurgeon's sophisticated peer-to-peer networking system.
All veterinary surgeons can visit and read content in the BVDA section on VetSurgeon. However, only BVDA members can join and participate.
A downloadable application form for BVDA membership is available from the 'About us' section.
Lisa Milella MRCVS, BVDA President said: "We're very excited about the potential that VetSurgeon offers us to share information about veterinary dentistry both amongst ourselves and with the wider profession"
Arlo Guthrie, editor and publisher of VetSurgeon said: "I'm really pleased to welcome the BVDA to VetSurgeon. They now sit alongside the Small Animal Medicine Society on the site, and I hope will be joined by more veterinary associations in the future, so that they are all conveniently in once place for easy availability to all practitioners."
Click here to visit the new BVDA section on VetSurgeon.
Novartis Animal Health Inc. has completed an agreement with Luitpold Pharmaceuticals, Inc. that grants marketing rights for Adequan® Equine to Novartis in all major equine markets outside the U.S. The first launch of Adequan® Equine by Novartis will take place in Canada in June.
Adequan® Equine is indicated for treating joint dysfunction and lameness in horses caused by injury or degenerative problems. It is available for intramuscular and intra-articular administration. Adequan® is also indicated for treating joint dysfunction and lameness caused by injury or degenerative problems in dogs.
Mickey McDermott from Novartis' Communications Dept told VetSurgeon that the timing of Adequan's arrival in the UK depends on how long it takes to complete the registration transfers, but that the company hopes it'll be before the end of the year.
The Society of Practising Veterinary Surgeons (SPVS) has inaugurated its new President Iain Richards BVSc CertVA Cert SHP MRCVS, who has outlined the key issues he would like to address during his presidency:
"The reform of the Veterinary Surgeons Act will be a big part of the SPVS year. Any changes of the VSA are likely to hit practitioners hardest of all. It was to ensure public confidence that the RCVS was formed, and it is with the public that we have our daily interactions. It is satisfying to note, despite what some of the EFRACOM committee felt, that the proportion of actual complaints in comparison to public interactions is very small indeed. This point must not be lost on the RCVS or government. The profession is already held in high esteem by the public and any new act has to reinforce that.
Alongside the VSA are the closely related aspects of 24hr cover and the Working Time Regulations. Indeed, it is no coincidence that our high public esteem is in part due to the willingness of the practicing arm of the profession to make itself available at all times. The WTR has a long way to go, but has the potential to make this aspect of our work untenable.
Farm practice continues to have its own challenges. Despite opinion suggesting that farms do well in a recession, the challenges are still out there. It is a rapidly changing field with issues of medicines supply still causing problems. TB will spread and more practices will have to look hard at the return LVI work provides. By adopting SPVS advice on fee construction and cost centre analysis, practices can accurately assess the true impact of this and any other revenue stream.
Small animal and many equine practices will potentially feel the recession the most, as both operate in a luxury market. The 2009 Congress theme, and that of the SPVS stream at the BVA Congress in Cardiff, is "Surviving the Recession".
The Society will be at the forefront in providing solid advice to practices to enable them to thrive in such circumstances. Recessions have come and gone and we have a wealth of experience from previous SPVS members to draw upon. One thing is clear, providing a quality service is vital. To the client, this has to be a value for money service as well. Marrying these two is key to business success and SPVS council will be working towards these objectives. It is likely that those practices that adapt and survive a recession will be in a strong position in the future.
Quality and value apply to practices, regardless of their species grouping. At home in Kendal, my practice is pushing standards forwards in equine, farm and small animal work. Because of this I am lucky to be able to indulge in being a mixed practitioner who has a keen interest in all aspects of veterinary work. This places me in a good position to represent the Society of Practising Veterinary Surgeons at all levels and to all bodies. SPVS is a great society; it is a pleasure to be picked for the team.
My vision goes beyond the year, however, and would encapsulate a desire that SPVS works with the other divisions of BVA to ensure that the veterinary profession provides the foremost view of all aspects of animal welfare and disease."
A survey carried out in 2008 by the British Veterinary Association and its student branch, the Association of Veterinary Students (AVS) has found that that one in three students find themselves in difficult or severe financial situations, more than half have suffered from stress, over a fifth from depression, over a quarter from anxiety and one in every 14 from an eating disorder.
The survey also found that some veterinary schools have almost doubled their intake of overseas veterinary students since the survey was last conducted in 2005.
Other key findings from the survey included:
The AVS suggests that there are opportunities for veterinary schools and the veterinary profession to improve the bleak financial picture for students. BVA already provides support meetings for young professionals and has put together a position statement which will kick-start a lobbying process for:
BVA President Nicky Paull said: "The BVA/AVS survey, a part of the BVA's continuing work on behalf of veterinary students, once again continues to highlight the growing problem of debt. This is a particular problem for veterinary undergraduates whose five year course by definition will attract more debt than the average three year undergraduate course.
"The impact of this increasing debt is twofold. Firstly, new graduates are more likely to choose their first jobs on the basis of salary and reducing debt rather than individual professional development. Secondly, we are concerned that as school leavers make career decisions on financial grounds, only those from relatively affluent backgrounds will choose the veterinary profession. This is contrary to the aims of Government to promote the DfES/Gateway to the Professions initiative. It would be sad to see such a vitally important undergraduate course become one which can only be undertaken by talented young people from families who feel they can afford to help with the long term costs.
"The veterinary undergraduate course is not only training future veterinarians on animal health and welfare but also in the essential role vets play in food safety and the health of the nation."
The full survey results can be downloaded here.
Intervet/Schering-Plough Animal Health is to launch CICADA-Live, the second phase of its national initiative to monitor the awareness and regional prevalence of important diseases in cats, dogs and rabbits.
First launched in 2007 as a quarterly survey, the ground-breaking CICADA-Live project has now been developed to offer up-to-the minute data on infectious companion animal disease reports that can be updated and accessed by vet practices around the clock. The new scheme is now able to provide a real-time overview of companion animal infectious diseases being diagnosed in UK veterinary practices.
CICADA-Live is focusing on more than a dozen key infectious diseases of dogs, cats and rabbits. They include canine parvovirus, infectious canine hepatitis, canine distemper, leptospirosis, kennel cough, angiostrongylosis. For cats, CICADA-Live will monitor feline panleucopaenia, cat flu, feline leukaemia virus infections. For rabbits the focus will be on myxomatosis, rabbit viral haemorrhagic disease, E.cuniculi, and fly strike.
The service is officially launched on 1st June to coincide with Intervet/Schering-Plough Animal Health's National Vaccination Month 2009, and is open to all first-opinion UK companion animal veterinary practices.
The system's developer, John Helps, Veterinary Manager at Intervet/Schering-Plough Animal Health said: "Whereas our first edition of CICADA was useful in providing benchmarks so that seasonal and long term trends could be identified and communicated to both vets and pet owners, the further potential of a live on-line database is enormous in raising awareness of current pet disease risks to the public."
According to the company, there has been a lack of knowledge regarding the local and national incidence of small animal infectious diseases in the UK, and those sporadic reports that do occur are typically anecdotal and can prove hard to substantiate. It is feared that the lack of co-ordinated good quality information has potentially lead to pet owners being lulled into a false sense of security by a low awareness of disease risks.
John added: "Lack of data on the incidence and prevalence of even the most common infectious diseases has been an important issue faced by small animal practices reducing their ability to highlight these risks. A staggering lack of owner awareness to infectious disease threats in turn contributes to complacency among pet owners.
"Evidence suggests that some infectious diseases, such as parvovirus, may be on the increase in some areas and there continues to be a concern regarding the number of animals that remain unvaccinated.
"Not only will Cicada-Live provide the means for improving a gap in our collective knowledge but it will also prove invaluable in the promotion of good preventative healthcare.
"We have long believed that better epidemiological surveillance would an important tool in understanding trends in small animal infectious disease and with CICADA-Live, for the first time we have a tool to give us a better appreciation of what first opinion practices are currently seeing."
The CICADA-Live website, http://www.cicadasurvey.co.uk/, is simple to access and update. Registrations are limited to one per practice branch. A straightforward one-page survey format minimises the time investment, with no strict requirement to review written case records.
Once signed in, participating practices will be asked to complete the survey once every 6 months in order to grant continued access to maps and tables showing recent reports. In addition practices can set up e-mail alerts to give notification should disease reports be received in their area.
For further information about CICADA-Live from Intervet please contact Intervet /Schering-Plough Animal Health's Veterinary Support Group on 01908 685685. Or contact John.
A donation of 200 Tracer microchips by Bayer is helping to save one of the world's largest and rarest species of frog against extinction. A deadly fungal disease, responsible for decimating global amphibian populations, is threatening the last known wild population of the 'mountain chicken' frog (Leptodactylus fallax).
The eastern Caribbean island of Montserrat is the last global stronghold for this species - known locally as mountain chicken due to its taste. As recently as 2002, chytridomycosis wiped out the majority of mountain chicken frogs on the island of Dominica. Recent tests on dead frogs found in the west of Montserrat have confirmed the presence of this disease.
The Durrell Wildlife Conservation Trust has been working in Montserrat since the early 1990s to support the local government in the protection of the island's vast biodiversity. The mountain chicken has been an important species, and Durrell holds the largest safety net population at its Jersey headquarters.
In response to the positive identification of the disease, Durrell has launched an emergency plan to rescue healthy frogs and put in place longer treatment and management plans for the protection of the species.
Bayer's donation of 200 Tracer microchips will be used to individually identify the captive mountain chickens held by Durrell to help manage a breeding programme. Durrell is also testing the feasibility of treating the frogs with antifungals in their natural habitat, and the use of the donation of microchips will be essential to allow individual frogs to be monitored to assess the outcomes of treatment regimes.
Durrell's head of veterinary services, Javier López, has worked with mountain chickens for a number of years, and explains that the disease could very quickly wipe out the species. Captive populations of healthy frogs, such as the one in Jersey, could be used to initiate re-introductions back to the wild or in disease-free areas.